You are here Home Vaccines Vaccines Havrix 1440 Details for Havrix 1440 (hepatitis A) vaccine and its components. Listen Print Share Twitter Facebook Email Recently added This page was added on 04 June 2018. Updates made This page was updated on [date-counter-updated-date]. View history of updates Sponsor GlaxoSmithKline Australia Administration route Intramuscular injection Vaccine group Monovalent vaccines Description: Registered for use in people aged ≥16 years. Each 1.0 mL monodose vial or pre-filled syringe contains: 1440 ELISA units of inactivated hepatitis A virus (HM175 strain) 0.5 mg aluminium as aluminium hydroxide hydrate Also contains traces of: formaldehyde neomycin polysorbate 20 For Product Information and Consumer Medicine Information about Havrix 1440 visit the Therapeutic Goods Administration website. Additional vaccine information For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s. Related diseases Hepatitis A Page history Last updated 27 September 2021 Last reviewed 27 September 2021 Is there anything wrong with this page? Help us improve the Australian Immunisation Handbook What you were doing? (required) What went wrong? (required) Leave this field blank
